Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 4/20 | 0.62 |
| ▸ | IDO1 | P14902 | 2/20 | 0.49 |
| ▸ | TDO2 | P48775 | 1/20 | 0.49 |
| ▸ | MIF | P14174 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | CASP3 | P42574 | 1/20 | 0.47 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.47 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.47 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28271036 | 0.86 | NPC1 (0.74) | NPC1MIFL3MBTL1CASP3SENP8 | |
| SCHEMBL11756645 | 0.85 | NPC1 (0.46) | NPC1IDO1TDO2L3MBTL1CASP3 | |
| SCHEMBL5470573 | 0.79 | NPC1 (0.63) | NPC1IDO1TDO2MIFL3MBTL1 | |
| SCHEMBL807820 | 0.77 | NPC1 (0.62) | NPC1IDO1L3MBTL1CASP3SENP8 | |
| SCHEMBL31175948 | 0.77 | NPC1 (0.62) | NPC1IDO1L3MBTL1CASP3SENP8 | |
| SCHEMBL23599072 | 0.77 | NPC1 (0.62) | NPC1IDO1MIFL3MBTL1CASP3 | |
| SCHEMBL731645 | 0.77 | NPC1 (0.62) | NPC1L3MBTL1CASP3SENP8SENP7 | |
| SCHEMBL3832405 | 0.77 | NPC1 (0.62) | NPC1IDO1L3MBTL1CASP3SENP8 | |
| SCHEMBL21705041 | 0.76 | NPC1 (0.61) | NPC1MIFL3MBTL1CASP3SENP8 | |
| SCHEMBL21173257 | 0.74 | NPC1 (0.59) | NPC1IDO1TDO2L3MBTL1CASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11814401-B2 | Luminescent material and electroluminescent display device using the same | LG DISPLAY CO., LTD (KR) | 2023-11-14 | — | — | US | disclosed |
| US-11814401-B2 | Luminescent material and electroluminescent display device using the same | LG DISPLAY CO., LTD (KR) | 2023-11-14 | — | — | US | disclosed |
| US-20210198298-A1 | LUMINESCENT MATERIAL AND ELECTROLUMINESCENT DISPLAY DEVICE USING THE SAME | LG DISPLAY CO., LTD. (KR) | 2021-07-01 | — | — | US | disclosed |
| US-8900722-B2 | OLED device employing alkali metal cluster compounds | GLOBAL OLED TECHNOLOGY LLC (US) | 2014-12-02 | — | — | US | disclosed |
| US-20090142618-A1 | OLED DEVICE EMPLOYING ALKALI METAL CLUSTER COMPOUNDS | GLOBAL OLED TECHNOLOGY LLC | 2009-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11814401-B2 | Luminescent material and electroluminescent display device using the same | ALDH1A2, CD99, EPB41L2 | NPC1 4328/4885IDO1 2412/4885TDO2 936/4885 |
| US-20210198298-A1 | LUMINESCENT MATERIAL AND ELECTROLUMINESCENT DISPLAY DEVICE USING THE SAME | ALDH1A2, CD99, EPB41L2 | NPC1 4328/4885IDO1 2412/4885TDO2 936/4885 |
| US-20090142618-A1 | OLED DEVICE EMPLOYING ALKALI METAL CLUSTER COMPOUNDS | OCIAD2, OCIAD1, OSTC | NPC1 906/4885IDO1 1164/4885TDO2 2126/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.